Page results
-
Once you have completed treatment for breast cancer at UCLH you will enter a period of follow-up care. Follow-up is an important way of monitoring your health. It allows us to identify any signs that…
-
This booklet is designed for teenagers and young people. It explains what you can expect when you finish your treatment for Hodgkin lymphoma.
-
You have been given this information because your unborn baby (fetus) has been diagnosed with spina bifida. This news must have been stressful for you and your partner/family, and you will have to…
-
The Leishmaniasis Multidisciplinary Team (MDT) The leishmaniasis MDT aims to support clinicians around the UK in the investigation and management of patients with suspected or confirmed…
-
This page is for patients who have been offered CT guided spinal steroid injections.
-
Thalassaemia is a group of inherited blood conditions where the part of the blood known as haemoglobin is abnormal.
-
This page explains what adrenal surgery is and provides information about what it involves. It also provides information about the risks and benefits of adrenal surgery.
-
UCLH is a designated specialist centre for the treatment of head and neck cancer for people in north and east London and west Essex.
-
Sickle cell disorder is the most common genetic (inherited) disorder in the United Kingdom.
-
The UCLH Lymphoma multidisciplinary team (MDT) provides specialist care for people with lymphoma.
File results
-
FOI/2021/0341 - Total hospital deaths (all causes)
-
FOI/2021/0351 - Patients brought to A&E presenting complaint related to mental health
-
FOI/2021/0363 - Robot assisted laparascopic prostatectomy cost
-
FOI/2021/0364 - Proton Beam Therapy unit/ machine
-
FOI/2021/0377 - Stonewall diversity applications
-
FOI/2021/0431 - Data Security and Protections Toolkit
-
FOI/2021/0437 - Trust’s surgical power tool inventory
-
FOI/2021/0438 - Dermatology service costs and contract values
-
FOI/2021/0458 - Breathing filters used in mechanical ventilators for (COVID-19) patients
-
FOI/2021/0459 - Total IT budget